{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T14:26:23Z","timestamp":1795011983174,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T00:00:00Z","timestamp":1477008000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12889-016-3738-x","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T22:58:26Z","timestamp":1477004306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy"],"prefix":"10.1186","volume":"16","author":[{"given":"Katsiaryna","family":"Holl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Sauboin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Amodio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gabutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,21]]},"reference":[{"key":"3738_CR1","unstructured":"CDC VPD Surveillance Manual, 5th Edition, 2011 Varicella: Chapter 17\u20131; \n                    http:\/\/www.cdc.gov\/vaccines\/pubs\/surv-manual\/chpt17-varicella.pdf\n                    \n                   Accessed 6 June 2016."},{"issue":"45","key":"3738_CR2","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.1016\/j.vaccine.2007.07.036","volume":"25","author":"A Nardone","year":"2007","unstructured":"Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine. 2007;25(45):7866\u201372.","journal-title":"Vaccine"},{"key":"3738_CR3","unstructured":"European Center for Disease Prevention and Control Guidance. Varicella vaccination in the European Union. ECDC; 2015. \n                    http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/Varicella-Guidance-2015.pdf\n                    \n                  . Accessed 1 July 2016."},{"issue":"11","key":"3738_CR4","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1099\/jmm.0.000061","volume":"64","author":"C Trucchi","year":"2015","unstructured":"Trucchi C, Gabutti G, Rota MC, Bella A. Burden of varicella in Italy, 2001\u20132010: analysis of data from multiple sources and assessment of universal vaccination impact in three pilot regions. J Med Microbiol. 2015;64(11):1387\u201394.","journal-title":"J Med Microbiol"},{"key":"3738_CR5","unstructured":"The World Health Organization. Varicella and herpes zoster vaccines: WHO position paper Wkly Epidemiol Rec. 2014;89(25):265\u201388."},{"issue":"1","key":"3738_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4161\/hv.34311","volume":"11","author":"A Bechini","year":"2015","unstructured":"Bechini A, Boccalini S, Baldo V, Cocchio S, Castiglia P, Gallo T, et al. Impact of universal vaccination against varicella in Italy: experiences from eight Italian regions. Hum Vaccin Immunother. 2015;11(1):63\u201371.","journal-title":"Hum Vaccin Immunother"},{"key":"3738_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1017\/S0950268800004714","volume":"125","author":"M Brisson","year":"2000","unstructured":"Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000;125:651\u201369.","journal-title":"Epidemiol Infect"},{"issue":"19","key":"3738_CR8","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1016\/j.vaccine.2010.02.079","volume":"28","author":"M Brisson","year":"2010","unstructured":"Brisson M, Melkonyan G, Drolet M, De Serres G, Thibeault R, De Wals P. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster. Vaccine. 2010;28(19):3385\u201397.","journal-title":"Vaccine"},{"issue":"4","key":"3738_CR9","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.clinthera.2014.12.017","volume":"37","author":"MJ Ouwens","year":"2015","unstructured":"Ouwens MJ, Littlewood KJ, Sauboin C, T\u00e9hard B, Denis F, Bo\u00eblle PY, et al. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix. Clin Ther. 2015;37(4):816\u201329.","journal-title":"Clin Ther"},{"issue":"3","key":"3738_CR10","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1371\/journal.pmed.0050074","volume":"5","author":"J Mossong","year":"2008","unstructured":"Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008;5(3):e74.","journal-title":"PLoS Med"},{"key":"3738_CR11","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S0140-6736(12)61461-5","volume":"383","author":"R Prymula","year":"2014","unstructured":"Prymula R, Bergsaker MR, Esposito S, Gothefors L, Man S, Snegova N, et al. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial. Lancet. 2014;383:1313\u201324.","journal-title":"Lancet"},{"key":"3738_CR12","unstructured":"National Centre for Immunisation Research & Surveillance (NCIRS). Varicella history Australia (Dec 2013). \n                    http:\/\/www.ncirs.edu.au\/assets\/provider_resources\/history\/Varicella-history-December-2013.pdf\n                    \n                   Accessed 9 October 2015."},{"issue":"8","key":"3738_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.2471\/BLT.13.132142","volume":"92","author":"AE Heywood","year":"2014","unstructured":"Heywood AE, Wang H, Macartney KK, McIntyre P. Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study. Bull World Health Organ. 2014;92(8):593\u2013604.","journal-title":"Bull World Health Organ"},{"issue":"13","key":"3738_CR14","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1016\/j.vaccine.2010.01.036","volume":"28","author":"KS Carville","year":"2010","unstructured":"Carville KS, Riddell MA, Kelly HA. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia. Vaccine. 2010;28(13):2532\u20138.","journal-title":"Vaccine"},{"key":"3738_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/1471-2334-13-303","volume":"13","author":"A Streng","year":"2013","unstructured":"Streng A, Grote V, Carr D, Hagemann C, Liese JG. Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006\u20132011. BMC Infect Dis. 2013;13:303.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"3738_CR16","first-page":"275","volume":"3","author":"M Garc\u00eda Cenoz","year":"2014","unstructured":"Garc\u00eda Cenoz M. Varicella vaccination programs do not seem to shift the age of disease to older age groups. (Editorial) Transl Pediatr. 2014;3(4):275\u20137.","journal-title":"(Editorial) Transl Pediatr"},{"issue":"7","key":"3738_CR17","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1097\/INF.0b013e31828b7def","volume":"32","author":"P Bonanni","year":"2013","unstructured":"Bonanni P, Gershon A, Gershon M, Kulcs\u00e1r A, Papaevangelou V, Rentier B, et al. Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses. Pediatr Infect Dis J. 2013;32(7):e305\u201313.","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 2","key":"3738_CR18","doi-asserted-by":"publisher","first-page":"S156","DOI":"10.1086\/522135","volume":"197","author":"F Zhou","year":"2008","unstructured":"Zhou F, Ortega-Sanchez IR, Guris D, Shefer A, Lieu T, Seward JF. An economic analysis of the universal varicella vaccination program in the United States. J Infect Dis. 2008;197 Suppl 2:S156\u201364.","journal-title":"J Infect Dis"},{"issue":"1","key":"3738_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4161\/hv.36153","volume":"11","author":"S Tafuri","year":"2015","unstructured":"Tafuri S, Fortunato F, Cappelli MG, Cozza V, Bechini A, Bonanni P, et al. Effectiveness of vaccination against varicella in children under 5\u00a0years in Puglia, Italy 2006\u20132012. Hum Vaccin Immunother. 2015;11(1):214\u20139.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"3738_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4161\/hv.36157","volume":"11","author":"E Amodio","year":"2014","unstructured":"Amodio E, Tramuto F, Cracchiolo M, Sciuto V, De Donno A, Guido M, et al. The impact of ten years of infant universal varicella vaccination in Sicily, Italy (2003\u20132012). Hum Vaccin Immunother. 2014;11(1):236\u20139.","journal-title":"Hum Vaccin Immunother"},{"issue":"RR-4","key":"3738_CR21","first-page":"1","volume":"56","author":"M Marin","year":"2007","unstructured":"Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-4):1\u201340.","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"3738_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1542\/peds.2010-3385","volume":"128","author":"M Marin","year":"2011","unstructured":"Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics. 2011;128(2):214\u201320.","journal-title":"Pediatrics"},{"issue":"3","key":"3738_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/infdis\/jiq052","volume":"203","author":"ED Shapiro","year":"2011","unstructured":"Shapiro ED, Vazquez M, Esposito D, Holabird N, Steinberg SP, Dziura J, et al. Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis. 2011;203(3):312\u20135.","journal-title":"J Infect Dis"},{"issue":"25","key":"3738_CR24","first-page":"265","volume":"89","author":"World Health Organization (WHO)","year":"2014","unstructured":"World Health Organization (WHO). Varicella position paper. Wkly Epidemiol Rec. 2014;89(25):265\u201387.","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"3738_CR25","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1542\/peds.2010-0665","volume":"126","author":"NP Klein","year":"2010","unstructured":"Klein NP, Fireman B, Yih WK, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics. 2010;126(1):e1\u20138. \n                    http:\/\/dx.doi.org\/10.1542\/peds.2010-0665\n                    \n                  .","journal-title":"Pediatrics"},{"issue":"6","key":"3738_CR26","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.vaccine.2013.12.011","volume":"32","author":"T Schink","year":"2014","unstructured":"Schink T, Holstiege J, Kowalzik F, et al. Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR\u2009+\u2009V vaccination. Vaccine. 2014;32(6):645\u201350. \n                    http:\/\/dx.doi.org\/10.1016\/j.vaccine.2013.12.011\n                    \n                  .","journal-title":"Vaccine"},{"issue":"39","key":"3738_CR27","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.1016\/j.vaccine.2014.07.024","volume":"32","author":"N Gavrielov-Yusim","year":"2014","unstructured":"Gavrielov-Yusim N, Hoshen M, Singer SR, et al. The weight of MMRV-related febrile convulsions among other clinical factors contributing to febrile convulsions in children. Vaccine. 2014;32(39):4954\u20139. \n                    http:\/\/dx.doi.org\/10.1016\/j.vaccine.2014.07.024\n                    \n                  .","journal-title":"Vaccine"},{"issue":"11","key":"3738_CR28","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1503\/cmaj.140078","volume":"186","author":"SE MacDonald","year":"2014","unstructured":"MacDonald SE, Dover DC, Simmonds KA, et al. Risk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study. CMAJ. 2014;186(11):824\u20139. \n                    http:\/\/dx.doi.org\/10.1503\/cmaj.140078\n                    \n                  .","journal-title":"CMAJ"},{"issue":"Suppl 1","key":"3738_CR29","doi-asserted-by":"publisher","first-page":"A3","DOI":"10.1186\/1824-7288-40-S1-A3","volume":"40","author":"RG Vitali","year":"2014","unstructured":"Vitali RG. Chickenpox vaccination. Ital J Pediatr. 2014;40 Suppl 1:A3.","journal-title":"Ital J Pediatr"},{"issue":"8","key":"3738_CR30","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.vaccine.2013.12.065","volume":"32","author":"A Streng","year":"2014","unstructured":"Streng A, Liese JG. Decline of varicella vaccination in German surveillance regions after recommendation of separate first-dose vaccination for varicella and measles-mumps-rubella. Vaccine. 2014;32(8):897\u2013900.","journal-title":"Vaccine"},{"issue":"11","key":"3738_CR31","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s40264-015-0326-4","volume":"38","author":"V Bauchau","year":"2015","unstructured":"Bauchau V, Van Holle L, Cohen C. Modelling hospitalisation ratios for febrile convulsions and severe varicella under combined Measles, Mumps, Rubella, and Varicella (MMRV-Priorix-Tetra\u2122) compared to separate MMR\u2009+\u2009V vaccination. Drug Saf. 2015;38(11):1095\u2013102.","journal-title":"Drug Saf"},{"issue":"12","key":"3738_CR32","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1086\/430325","volume":"191","author":"AO Jumaan","year":"2005","unstructured":"Jumaan AO, Yu O, Jackson LA, et al. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992\u20132002. J Infect Dis. 2005;191(12):2002\u20137.","journal-title":"J Infect Dis"},{"issue":"2","key":"3738_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/cid\/ciw296","volume":"63","author":"K Kawai","year":"2016","unstructured":"Kawai K, Yawn BP, Wollan P, Harpaz R. Increasing incidence of herpes zoster over a 60-year period from a population-based study. Clin Infect Dis. 2016;63(2):221\u20136.","journal-title":"Clin Infect Dis"},{"issue":"27\u201330","key":"3738_CR34","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1016\/S0264-410X(03)00459-6","volume":"21","author":"GS Goldman","year":"2003","unstructured":"Goldman GS. Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage. Vaccine. 2003;21(27\u201330):4243\u20139.","journal-title":"Vaccine"},{"key":"3738_CR35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1471-2458-5-68","volume":"5","author":"WK Yih","year":"2005","unstructured":"Yih WK, Brooks DR, Lett SM, et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998\u20132003. BMC Public Health. 2005;5:68.","journal-title":"BMC Public Health"},{"issue":"12","key":"3738_CR36","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1086\/591975","volume":"29","author":"MS Patel","year":"2008","unstructured":"Patel MS, Gebremariam A, Davis MM. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Infect Control Hosp Epidemiol. 2008;29(12):1157\u201363.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"3738_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/S095026880400281X","volume":"133","author":"JP Mullooly","year":"2005","unstructured":"Mullooly JP, Riedlinger K, Chun C, et al. Incidence of herpes zoster, 1997\u20132002. Epidemiol Infect. 2005;133(2):245\u201353.","journal-title":"Epidemiol Infect"},{"issue":"3","key":"3738_CR38","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/cid\/ciq077","volume":"52","author":"J Leung","year":"2011","unstructured":"Leung J, Harpaz R, Molinari NA, et al. Herpes zoster incidence among insured persons in the United States, 1993\u20132006: evaluation of impact of varicella vaccination. Clin Infect Dis. 2011;52(3):332\u201340.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3738_CR39","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1017\/S0950268807007893","volume":"135","author":"ML Russell","year":"2007","unstructured":"Russell ML, Schopflocher DP, Svenson L, et al. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect. 2007;135(6):908\u201313.","journal-title":"Epidemiol Infect"},{"issue":"9","key":"3738_CR40","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.4161\/hv.25228","volume":"9","author":"B Unim","year":"2013","unstructured":"Unim B, Saulle R, Boccalini S, Taddei C, Ceccherini V, Boccia A, Bonanni P, La Torre G. Economic evaluation of Varicella vaccination: results of a systematic review. Hum Vaccin Immunother. 2013;9(9):1932\u201342.","journal-title":"Hum Vaccin Immunother"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-016-3738-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-016-3738-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-016-3738-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T16:33:56Z","timestamp":1492533236000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-016-3738-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,21]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["3738"],"URL":"https:\/\/doi.org\/10.1186\/s12889-016-3738-x","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,21]]},"article-number":"1103"}}